Bausch Health Cos Share Holder Equity 2012-2026 | BHC
Bausch Health Cos share holder equity from 2012 to 2026. Share holder equity can be defined as the sum of preferred and common equity items
|
Bausch Health Cos Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025 | $377 |
| 2024 | $-322 |
| 2023 | $-82 |
| 2022 | $260 |
| 2021 | $-34 |
| 2020 | $605 |
| 2019 | $1,136 |
| 2018 | $2,815 |
| 2017 | $5,944 |
| 2016 | $3,258 |
| 2015 | $6,029 |
| 2014 | $5,402 |
| 2013 | $5,233 |
| 2012 | $3,717 |
| 2011 | $3,930 |
|
Bausch Health Cos Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2026-06-30 | $-802 |
| 2026-03-31 | $-1,082 |
| 2025-12-31 | $377 |
| 2025-09-30 | $356 |
| 2025-06-30 | $147 |
| 2025-03-31 | $-240 |
| 2024-12-31 | $-322 |
| 2024-09-30 | $-242 |
| 2024-06-30 | $-227 |
| 2024-03-31 | $-174 |
| 2023-12-31 | $-82 |
| 2023-09-30 | $-235 |
| 2023-06-30 | $271 |
| 2023-03-31 | $145 |
| 2022-12-31 | $260 |
| 2022-09-30 | $433 |
| 2022-06-30 | $253 |
| 2022-03-31 | $-141 |
| 2021-12-31 | $-34 |
| 2021-09-30 | $-135 |
| 2021-06-30 | $-611 |
| 2021-03-31 | $-124 |
| 2020-12-31 | $605 |
| 2020-09-30 | $655 |
| 2020-06-30 | $546 |
| 2020-03-31 | $790 |
| 2019-12-31 | $1,136 |
| 2019-09-30 | $2,560 |
| 2019-06-30 | $2,688 |
| 2019-03-31 | $2,779 |
| 2018-12-31 | $2,815 |
| 2018-09-30 | $3,237 |
| 2018-06-30 | $3,558 |
| 2018-03-31 | $4,523 |
| 2017-12-31 | $5,944 |
| 2017-09-30 | $5,422 |
| 2017-06-30 | $4,029 |
| 2017-03-31 | $3,994 |
| 2016-12-31 | $3,258 |
| 2016-09-30 | $4,274 |
| 2016-06-30 | $5,403 |
| 2016-03-31 | $5,776 |
| 2015-12-31 | $6,029 |
| 2015-09-30 | $6,465 |
| 2015-06-30 | $6,558 |
| 2015-03-31 | $6,575 |
| 2014-12-31 | $5,402 |
| 2014-09-30 | $5,234 |
| 2014-06-30 | $5,367 |
| 2014-03-31 | $5,204 |
| 2013-12-31 | $5,233 |
| 2013-09-30 | $5,061 |
| 2013-06-30 | $5,703 |
| 2013-03-31 | $3,587 |
| 2012-12-31 | $3,717 |
| 2012-09-30 | $3,785 |
| 2012-06-30 | $3,695 |
| 2012-03-31 | $4,076 |
| 2011-12-31 | $3,930 |
| 2011-09-30 | $4,014 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $2.129B | $10.266B |
| Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $44.899B | 17.67 |
| BridgeBio Pharma (BBIO) | United States | $13.352B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $9.749B | 24.85 |
| Aspen Pharmacare (APNHY) | South Africa | $4.248B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.409B | 20.18 |
| Personalis (PSNL) | United States | $1.687B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $1.652B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.019B | 9.58 |
| Assembly Biosciences (ASMB) | United States | $0.519B | 24.98 |
| Sol-Gel Technologies (SLGL) | Israel | $0.178B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.043B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |